Litigation Details for TEAMSTERS LOCAL 237 WELFARE FUND v. AMGEN INC. (D.N.J. 2019)
✉ Email this page to a colleague
TEAMSTERS LOCAL 237 WELFARE FUND v. AMGEN INC. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-03-14 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-08-05 |
| Cause | 15:1 Antitrust Litigation | Assigned To | Esther Salas |
| Jury Demand | Plaintiff | Referred To | Cathy L. Waldor |
| Patents | 6,001,884; 6,011,068; 6,211,244; 6,313,146; 7,829,595; 9,375,405 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in TEAMSTERS LOCAL 237 WELFARE FUND v. AMGEN INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Biologic Drugs cited in TEAMSTERS LOCAL 237 WELFARE FUND v. AMGEN INC.
The biologic drug covered by the patents cited in this case is ⤷ Sign Up .
Details for TEAMSTERS LOCAL 237 WELFARE FUND v. AMGEN INC. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-03-14 | 1 | Complaint | covering Sensipar – U.S. Patent Nos. 6,211,244 (expired on October 23, 2015); 6,001,884 (expiry December 14… One of Amgen’s patents for Sensipar, U.S. Patent No. 6,011,068 (the “’068 Patent”), was set to expire…certifications against the patents covering Sensipar. Among these patents was U.S. Patent No. 9,375,405 (“the…the ‘086 patent, the ’405 Patent was a formulation patent, which only covered a new formulation of the …, with the primary substance patent being the ’068 patent. These patents were originally were assigned | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
